Clinical effect of herbal paste combined with Femoston to treat Premature ovarian insufficiency (POI)

Tongxiang Maternal and Child Health Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Between 18 and 40 years of age;
•2. Those who meet the diagnostic criteria of TCM and Western medicine;
•3. Urine pregnancy test negative;
•4. Those who did not receive any relevant treatment within 3 months prior to the start of the study;
•5. Patients with informed consent and voluntary participation, can cooperate with the completion of clinical researchers.

•1. Female reproductive system anatomical abnormalities;
•2. In the past three months, the use of hormones, traditional Chinese medicine or acupuncture treatment;
•3. Complicated with other gynecological reproductive endocrine diseases, such as endometriosis, hyper prolactinemia, polycystic ovary syndrome, gonadal dysplasia;
•4. History of autoimmune diseases;
•5. Patients with severe primary diseases, such as cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system; Those who participated in other clinical trials at the same time did;
•6. Not end or took other drugs that affected the study;
•7. There are contraindications of acupuncture, such as large area of skin infection, rupture and so on;??
•8. Not according to the prescribed medication, can not judge the efficacy, or incomplete data and other effects on the efficacy of the judge.

发起方

Tongxiang Maternal and Child Health Hospital